Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
0.00
(
0.00%
)
US TECH 100
0.00
(
0.00%
)
Dow Jones
48,414.84
(
0.41%
)
Brent Oil
92.67
(
-2.93%
)
Bitcoin
74,604.01
(
0.14%
)
News Focus
News Focus
Post# of 405172
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biodoc

Send PM Follow Ignore
Followers 60
Posts 595
Boards Moderated 0
Alias Born 08/10/2014

biodoc

Re: slcimmuno post# 82398

Sunday, 12/14/2014 10:48:40 AM

Sunday, December 14, 2014 10:48:40 AM

Post# of 405172
A few more notes about Orbactiv:

(1) *Higher rate of osteomyelitis with Orbactiv as compared to Vancomycin
(2) Side effect profile comparable to Vancomycin (not very good)
(3) Significant drug interactions (esp. warfarin)
(4) 3 hour infusion time vs. 1 hour for Brilacidin

Orbactiv adverse effects

FWIW, I expect both a higher clinical response rate and clinical success rate for Brilacidin.


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote